Influenza vaccine, possibly latex scars in pre-filled syringe components or nasal applicators from 7 influenza vaccines produced by three pharmaceutical companies for the 2019-2020 season. A possibility is not excluded by the Italian Medicines Agency (Aifa) and which can be dangerous for people with latex allergies who, in the presence of this substance even in traces, will be exposed to the risk of allergic reactions. Therefore, the invitation of the Agency for allergy sufferers is to consult a doctor before the vaccine is given.
Influenza 2019, in bed 341 thousand Italians: the virus is almost epidemic
«The notice issued by Aifa only concerns the packaging of influenza vaccine to protect those allergic to this substance. This is to enable even those with adequate allergic vaccinations to let them know about latex-free products. Therefore, there is no contamination in the flu vaccine », according to the drug agent. Possible latex marks they are not related to the vaccine itself but rather external components such as, in fact, syringe elements such as cylinders, pistons, protective caps for needle covers and end caps, or they can be determined through contact during the production process.
Roma, 11-year-old girl at risk of infection: class and teacher vaccinated against measles
Information campaign in progress #antinfluenzale. Beware of seasonal diseases and fight us against #fakenews. In vaccines follow the instructions #AIFA. @MinisteroSalute and @istsupsan pic.twitter.com/3uS8u1kPys
– AIFA (@Aifa_ufficiale) November 13, 2019
Cold and bronchial problems: an online guide to self-defense
It has nothing to do with cases like the Fluart flu vaccine by Novartis, which in 2014 several lots were withdrawn after reporting suspicious deaths after the product was given. In the case of 'lattice risk', AIFA has actually conducted in-depth studies with companies that hold vaccine authorization (AIC) to protect allergic sufferers. Based on EU guidelines, a warning is included in the Product Information Sheet if there is any amount of latex. However, in the absence of latex, the inclusion of specific declarations is not required.
Bimbo has leukemia, his friends get vaccinated to allow him to return to class
To better protect allergic people, AIFA still asks to state, if not mentioned in the leaflet, whether or not there are major packaging components, contact all the companies involved. Verification shows that for 7 vaccines the presence of latex is not excluded. This is the Mylan IRE HEALTHCARE LIMITED company with the vaccine 'Influvac S tetra' where AIFA stipulates that «it does not contain latex» but «cannot be excluded from the possibility that, during the production process, vaccines come into contact with devices containing latex"; the company Mylan Italia Srl with the vaccine 'Influvac S * & # 39; the company Seqirus srl with Agrippal S1, Fluad, Influpozzi, Innoflu *, Flucelvax tetra vaccines. who are sensitive to latex to consult their doctors before giving the vaccine.The aim, Aifa notes, is to provide "summary information to further contribute to the safe and correct use of seasonal flu vaccines even in those who have a history of severe allergic latex reactions".
THIS IS THE VACCINE DETAILS
– menfluvac S tetra * (Mylan Ire Healthcare Limited) «does not contain latex – it is likely that, during the production process, vaccines in contact with instruments containing latex cannot be excluded. Patients who are sensitive to latex are advised to consult a doctor before giving the vaccine ».
– Influvac S * (Mylan Italia S.r.l.) «does not contain latex – it is likely that, during the production process, vaccines in contact with instruments containing latex cannot be excluded. Patients who are sensitive to latex are advised to consult a doctor before giving the vaccine ».
– Fluarix tetra * (Glaxo Smith Kline Biologicals Sa) "does not contain latex – it is not used in the production process".
– Vaxigrip tetra * (Sanofi Pasteur Europe) "does not contain latex – it is not used in the production process".
As for Agrippal S1 *, Fluad *, Infunit Subunit *, Innoflu * and Flucelvax tetra * (Seqirus srl) «cannot be excluded that the needle cap and protective cap of the syringe do not contain latex. Patients who are sensitive to latex are advised to consult a doctor before giving the vaccine ». Finally Fluenz tetra * (AstraZeneca AB) «does not contain latex – it is not used in the production process».
Last updated at 9.16 at night
© REPRODUCTIONS PROTECTED